Variantyx, Inc.

Framingham,  MA 
United States
http://www.variantyx.com
  • Booth: 833

Profile

Variantyx offers to the clinical and research communities a comprehensive set of Whole Genome Diagnostics products and services for diagnosing rare genetic disorders.


 Press Releases

  • FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx announced the US launch of its proprietary clinical diagnostic platform at the American College of Medical Genetics (ACMG) conference in Phoenix, AZ. The Genomic Intelligence® platform automates the complete NGS testing process from sample collection to sequencing, data analysis, interpretation and clinical report generation, allowing ordering physicians to focus on making a diagnosis with the interactive support of Variantyx’ US Board Certified Geneticists. The end-to-end clinical diagnostic services are errors and omissions insured, HIPAA and CLIA compliant.

    Variantyx launches Genomic Intelligence Clinical Diagnostic Platform at ACMG in Phoenix, AZ.

    Tweet this

    As part of the US market launch, Variantyx is offering to review previously undiagnosed cases and provide a second opinion to clinicians at no cost. All clinicians have to do is authorize the testing laboratories to send the FASTQ or BAM files from whole exome, whole genome or panel sequencing and Variantyx will provide a clinical report of their findings.

    Variantyx CEO Haim Neerman states: “ Widely used by several hospitals around the world, the Genomic Intelligence® platform has processed thousands of samples and solved many previously undiagnosed, complex cases. Clinicians have nothing to lose, and patients have everything to gain, by getting a second opinion.” He welcomes the challenge and encourages clinicians to submit their unsolved cases at https://www.variantyx.com/request-a-demo/.

    Dr. Virginia Kimonis, Principal Investigator at the Division of Genetics and Genomics Medicine at UC Irvine School of Medicine states: “I was surprised how fast and easy it was to resolve my cases. The Genomic Intelligence® platform utilizes the best available public, proprietary and in-house developed resources to detect and report clinically actionable variants. The user-friendly console enables variant selection and clinical report generation so quickly, allowing one to review more cases in a single day.”

    About Variantyx: Specializing in whole genome analysis, Variantyx offers clinicians, hospitals and labs a comprehensive set of products and services for diagnosing rare genetic disorders. For more information, please visit www.variantyx.com.

    Contacts

    Variantyx
    Muthu Meyyappan, 617-209-2090 or 978-821-2399
    muthu.meyyappan@variantyx.com

Registration for ACMG 2017

Registration is open

March 21 - 25, 2017
Phoenix Convention Center
Phoenix, Arizona

Hotel Reservations

Make your hotel reservation here